Stock Analiz

BioAge Labs, Inc. (BIOA) stock forecast and price target

Price $5.55 · data as of November 13, 2026

12-month price target

Average target$28.89
Upside / downside+420.5%
Analysts9
ConsensusBuy
Low $8.00Average $28.89High $50.00

Gold marker: average target · white marker: today’s price ($5.55)

Analyst ratings

Strong buy 2Buy 5Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.57−14.7%$7M
Next fiscal year
ends December 31, 2027
$-2.62−2.0%$15M
Next quarter
ends December 31, 2026
$-0.73−1.5%$1M
Quarter after
ends March 31, 2027
$-0.69−33.2%$383330

Consensus of the analysts covering BioAge Labs, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the BioAge Labs stock price target?

The average 12-month target from 9 analysts is $28.89, 420.5% above the current price of $5.55 Targets range from $8.00 to $50.00.

Is BioAge Labs a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 5 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is BioAge Labs expected to earn?

Analysts expect EPS of $-2.57 for the fiscal year ending December 31, 2026 and $-2.62 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.